Prospective monitoring for anthracycline cardiotoxicity: an introduction.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin